Page History
...
In tobacco product studies, the Adverse Events (AE) domain is used for representing adverse experiences. The FDA's PMTA rule defines adverse experience as any unfavorable physical or psychological effect in a person that is temporally associated with the use of or exposure to a tobacco product, whether or not the person uses the tobacco product, and whether or not the effect is considered to be related to the use of or exposure to the tobacco product. In consultation with regulatory authorities, applicants may extend or limit the scope of collection (e.g., collecting pre-treatment exposure experiences related to trial conduct, not collecting events that are assessed as efficacy study endpoints). Events included in the AE domain should be consistent with protocol requirements.
Jira | ||||||||
---|---|---|---|---|---|---|---|---|
|
showSummary | false |
---|---|
server | Issue Tracker (JIRA) |
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
key | TOBA-256 |
Example | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
This is an example of a CRF used to collect all adverse experiences that occurred after informed consent was obtained. Adverse experiences were collected using free text. The CRF was designed to allow the applicant to use either AEENRF or AEENRTPT to represent an event that was ongoing.
This SDTM dataset illustrates data collected on the example AE CRF. This SDTM dataset used AENRTPT. For more information, see Section 2.8.7.6, Representing References and Relative Timing.
|
Pagenav